4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000100
Director acquired 4,216 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2023-06-01 | Grant or award | +4,216 | 147,218 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2023-06-01 | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | D: show line 2 in the form |
Loading xslF345X04/wk-form4_1686002853.xml…